Ramón Gomis

21.7k total citations · 6 hit papers
174 papers, 14.8k citations indexed

About

Ramón Gomis is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Ramón Gomis has authored 174 papers receiving a total of 14.8k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Endocrinology, Diabetes and Metabolism, 82 papers in Surgery and 56 papers in Molecular Biology. Recurrent topics in Ramón Gomis's work include Pancreatic function and diabetes (77 papers), Diabetes Management and Research (45 papers) and Diabetes and associated disorders (40 papers). Ramón Gomis is often cited by papers focused on Pancreatic function and diabetes (77 papers), Diabetes Management and Research (45 papers) and Diabetes and associated disorders (40 papers). Ramón Gomis collaborates with scholars based in Spain, United Kingdom and France. Ramón Gomis's co-authors include M Hanefeld, Hendrik Lehnert, Peter Arner, Jens Brøchner‐Mortensen, Steen Andersen, Avraham Karasik, Jean‐Louis Chiasson, Markku Laakso, Hans‐Henrik Parving and Robert G. Josse and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ramón Gomis

172 papers receiving 14.0k citations

Hit Papers

The Effect of Irbesartan on the Development of Diabetic N... 2001 2026 2009 2017 2001 2001 2002 2003 2009 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes
    2001 2.1k citations Ramón Gomis et al. profile →
  2. [Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
    2001 2.0k citations Ramón Gomis et al. profile →
  3. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
    2002 1.8k citations Ramón Gomis et al. profile →
  4. Acarbose Treatment and the Risk of Cardiovascular Disease and Hypertension in Patients With Impaired Glucose Tolerance
    2003 1.2k citations Ramón Gomis et al. profile →
  5. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
    2009 1.0k citations Ramón Gomis et al. profile →
  6. Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
    2007 561 citations Ramón Gomis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ramón Gomis Spain 47 8.6k 3.9k 3.8k 3.1k 1.9k 174 14.8k
Michel Marre France 66 8.7k 1.0× 3.8k 1.0× 3.9k 1.0× 3.3k 1.1× 2.3k 1.2× 423 17.2k
Masakazu Haneda Japan 67 5.4k 0.6× 2.4k 0.6× 4.8k 1.3× 2.7k 0.9× 2.3k 1.2× 292 16.1k
Robert E. Ratner United States 60 10.7k 1.3× 2.0k 0.5× 3.7k 1.0× 5.1k 1.6× 1.8k 1.0× 159 16.6k
Giorgio Sesti Italy 67 6.9k 0.8× 2.7k 0.7× 5.6k 1.5× 3.4k 1.1× 2.8k 1.5× 416 15.1k
Guntram Schernthaner Austria 60 6.2k 0.7× 1.4k 0.4× 2.9k 0.8× 2.7k 0.9× 1.7k 0.9× 227 11.0k
H. A. W. Neil United Kingdom 47 10.3k 1.2× 3.3k 0.8× 2.6k 0.7× 6.5k 2.1× 1.4k 0.7× 113 17.4k
Faramarz Ismail‐Beigi United States 53 9.3k 1.1× 2.1k 0.5× 5.0k 1.3× 2.8k 0.9× 2.4k 1.3× 203 16.6k
Paul N. Hopkins United States 63 5.7k 0.7× 5.3k 1.4× 2.9k 0.7× 5.0k 1.6× 1.9k 1.0× 295 16.2k
Itamar Raz Israel 67 15.2k 1.8× 6.4k 1.6× 6.1k 1.6× 5.6k 1.8× 3.3k 1.8× 374 26.0k
William C. Duckworth United States 45 7.2k 0.8× 1.8k 0.5× 3.8k 1.0× 3.0k 1.0× 1.9k 1.0× 202 13.0k

Countries citing papers authored by Ramón Gomis

Since Specialization
Citations

This map shows the geographic impact of Ramón Gomis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ramón Gomis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ramón Gomis more than expected).

Fields of papers citing papers by Ramón Gomis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ramón Gomis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ramón Gomis. The network helps show where Ramón Gomis may publish in the future.

Co-authorship network of co-authors of Ramón Gomis

This figure shows the co-authorship network connecting the top 25 collaborators of Ramón Gomis. A scholar is included among the top collaborators of Ramón Gomis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ramón Gomis. Ramón Gomis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandez‐Ruiz, Rebeca, Ainhoa García, Yaiza Esteban, et al.. (2020). Wisp1 is a circulating factor that stimulates proliferation of adult mouse and human beta cells. Nature Communications. 11(1). 5982–5982. 45 indexed citations
2.
Díaz‐Rizzolo, Diana A., Belchin Kostov, Mireia López‐Siles, et al.. (2019). Healthy dietary pattern and their corresponding gut microbiota profile are linked to a lower risk of type 2 diabetes, independent of the presence of obesity. Clinical Nutrition. 39(2). 524–532. 28 indexed citations
3.
Bertinat, Romina, Francisco Westermeier, Joana Oliveira, et al.. (2018). The Antidiabetic Agent Sodium Tungstate Induces Abnormal Glycogen Accumulation in Renal Proximal Tubules from Diabetic IRS2-Knockout Mice. Journal of Diabetes Research. 2018. 1–10. 11 indexed citations
4.
Rebuffat, Sandra A., et al.. (2016). Taurine Treatment Modulates Circadian Rhythms in Mice Fed A High Fat Diet. Scientific Reports. 6(1). 36801–36801. 25 indexed citations
5.
Esmatjes, Enric, Margarida Jansà, Daría Roca, et al.. (2014). The Efficiency of Telemedicine to Optimize Metabolic Control in Patients with Type 1 Diabetes Mellitus: Telemed Study. Diabetes Technology & Therapeutics. 16(7). 435–441. 52 indexed citations
6.
Amor, Antonio J., L. Masana, Federico Soriguer, et al.. (2014). Estimating Cardiovascular Risk in Spain by the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Revista Española de Cardiología (English Edition). 68(5). 417–425. 11 indexed citations
7.
Barberà, Albert, et al.. (2013). In Vivo JNK Activation in Pancreatic β-Cells Leads to Glucose Intolerance Caused by Insulin Resistance in Pancreas. Diabetes. 62(7). 2308–2317. 48 indexed citations
8.
Canivell, Sílvia, Elena G. Ruano, Antoni Sisó‐Almirall, et al.. (2013). Gastric Inhibitory Polypeptide Receptor Methylation in Newly Diagnosed, Drug-Naïve Patients with Type 2 Diabetes: A Case-Control Study. PLoS ONE. 8(9). e75474–e75474. 8 indexed citations
9.
Gomis, Ramón, et al.. (2013). Prevalencia de diabetes mellitus tipo 2 en pacientes ambulatorios con sobrepeso u obesidad en España. Estudio OBEDIA. Medicina Clínica. 142(11). 485–492. 20 indexed citations
10.
McCluskey, Jane T., Muhajir Hamid, Hong Guo-Parke, et al.. (2011). Development and Functional Characterization of Insulin-releasing Human Pancreatic Beta Cell Lines Produced by Electrofusion. Journal of Biological Chemistry. 286(25). 21982–21992. 115 indexed citations
11.
12.
Vidal, Josép & Ramón Gomis. (2008). Cross-Talk Between Obesity and Atherothrombosis. Revista Española de Cardiología. 8. 3–10. 3 indexed citations
13.
Gomis, Ramón. (2008). Presentation: The Threat of Metabolic Change. Revista Española de Cardiología. 8. 1–1. 1 indexed citations
14.
Casas, Sandra, Anna Novials, Frank Reimann, Ramón Gomis, & Fiona M. Gribble. (2008). Calcium elevation in mouse pancreatic beta cells evoked by extracellular human islet amyloid polypeptide involves activation of the mechanosensitive ion channel TRPV4. Diabetologia. 51(12). 2252–2262. 102 indexed citations
15.
Gasa, Rosa, et al.. (2000). The Role of Glucose and Its Metabolism in the Regulation of Glucokinase Expression in Isolated Human Pancreatic Islets. Biochemical and Biophysical Research Communications. 268(2). 491–495. 11 indexed citations
16.
Fernández-Álvarez, Josefa, et al.. (1999). Acarbose treatment or islet transplantation increase FAD-glycerophosphate dehydrogenase content in islets of diabetic rats. Medical science research. 27(6). 393–396.
17.
Costa, Andréa Miúra da, Marı́a Yolanda Rios, Roser Casamitjana, Ramón Gomis, & Ignacio Conget. (1998). High prevalence of abnormal glucose tolerance and metabolic disturbances in first degree relatives of NIDDM patients.. Diabetes Research and Clinical Practice. 41(3). 191–196. 20 indexed citations
18.
Novials, Anna, et al.. (1996). Pancreatic Islet Mitochondrial Glycerophosphate Dehydrogenase Deficiency in Two Animal Models of Non-Insulin-Dependent Diabetes Mellitus. Biochemical and Biophysical Research Communications. 220(3). 1020–1023. 13 indexed citations
19.
Novials, Anna, et al.. (1989). Improvement by insulin treatment of the early phase of glucose-stimulated insulin release in non-insulindependent diabetics explored after restoration of hyperglycemia. Medical science research. 17. 381–382. 6 indexed citations
20.
Gomis, Ramón, et al.. (1988). The effect of hypoglycemic sulfonylureas on human red blood cell transglutaminase activity. Diabetes Research and Clinical Practice. 5(1). 31–36. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michel Marre Breakdown of academic impact, for papers by Masakazu Haneda Breakdown of academic impact, for papers by Robert E. Ratner Breakdown of academic impact, for papers by Giorgio Sesti Breakdown of academic impact, for papers by Guntram Schernthaner Breakdown of academic impact, for papers by H. A. W. Neil Breakdown of academic impact, for papers by Faramarz Ismail‐Beigi Breakdown of academic impact, for papers by Paul N. Hopkins Breakdown of academic impact, for papers by Itamar Raz Breakdown of academic impact, for papers by William C. Duckworth
Rankless by CCL
2026